Review of Chromatography Methods for Purfication of Paraoxonase Enzyme
Abstract
Keywords
References
- Van Himbergen TM, Van Tits LJH, Roest M, Stalenhoef AFH. The story of PON1: how an organophosphate hydrolyzing enzyme is becoming a player in cardiovascular medicine. Neth J Med 2006;64(2):34–8.
- Hegele RA. Paraoxonase genes and disease. Ann Med. 1999;31: 217–224
- Protein Purifcation. Principles, high resolution methods and applications. Third edition. Edited by J-C Jansson, 2011. Publ. John Wiley & Sons. ISBN 978-0-471-74661-4.
- Renault F., Chabriere E., Andrieu JP , Dublet B., Masson P., Rochu D. Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography Journal of Chromatography B, 836 (2006) 15–21
- C.E. Furlong, R.J. Richter, C. Chapline, J.W. Crabb, Biochemistry 30 (1991) 10133.
- K N Gan, A Smolen, H W Eckerson and B N La Du Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition January 1991, 19 (1) 100-106
- Rodrigo L, Gil F, Hernandez AF, et al. Purification and characterization of paraoxon hydrolase from rat liver. Biochem J 1997;321: 595–601 Cebeci BK, Alım Z, Beydemir Ş. In vitro effects of pesticide exposure on the activity of the paraoxonase-1 enzyme from sheep liver microsomes Turk Journal of Chem (2014) 38: 512–520
- Beydemir S, Ekinci D, Ates O. (2009). In vitro effects of dexamethasone on human serum Paraoxonase-I (PON1) Activity. Hacettepe J Biol Chem, 37:197–205 Sinan S, Kockar F, Arslan O. Novel purification strategy for humanPON1 and inhibition of the activity by cephalosporin andaminoglikozide derived antibiotics. Biochimie 2006;88:565–74
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
Basak Gokce
This is me
Publication Date
December 31, 2018
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2018 Volume: 5 Number: 4